The present invention relates to a radically polymerizable composition comprising a hydroxylamine ester used to manufacture color filters. The invention further relates to novel hydroxylamine esters. The invention further relates to the use of hydroxylamine esters in all liquid crystal display components requiring post-baking. The present invention relates to a radically polymerizable composition comprising: (a) at least one alkaline developable resin; (b) at least one acrylate monomer; (c) at least a photoinitiator; (d) at least one hydroxylamine ester compound of formula (I) wherein R
a
represents an acyl radical; one of R
b
and R
c
represents hydrogen and the other one represents a substituent; or R
b
and R
c
both represent hydrogen or identical or different substituents; or R
b
and R
c
together represent oxygen; or R
b
and R
c
together form a ring; R
1
-R
4
each represent C
1
-C
6
alkyl; and R
5
and R
6
each represent independently of one another hydrogen, C
1
-C
6
alkyl or C
6
-C
10
aryl; or R
5
and R
6
together represent oxygen.
The present invention relates to a radically polymerizable composition comprising a hydroxylamine ester used to manufacture color filters. The invention further relates to novel hydroxylamine esters. The invention further relates to the use of hydroxylamine esters in all liquid crystal display components requiring post-baking. The present invention relates to a radically polymerizable composition comprising: (a) at least one alkaline developable resin; (b) at least one acrylate monomer; (c) at least a photoinitiator; (d) at least one hydroxylamine ester compound of formula (I) wherein Ra represents an acyl radical; one of Rb and Rc represents hydrogen and the other one represents a substituent; or Rb and Rc both represent hydrogen or identical or different substituents; or Rb and Rc together represent oxygen; or Rb and Rc together form a ring; R1-R4 each represent C1-C6 alkyl; and R5 and R6 each represent independently of one another hydrogen, C1-C6 alkyl or C6-C10 aryl; or R5 and R6 together represent oxygen.
IMMUNOASSAY STANDARDS AND MEASUREMENT OF TAU USING INTRA-ASSAY CALIBRATION STANDARDS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160033525A1
公开(公告)日:2016-02-04
The present invention provides novel peptides, compositions, and methods for creating quantitative novel compositions, as well as methods for creating quantitative standards to calibrate analytes. These peptides, compositions, and methods enable the creation of standards and calibrators for analyzing analytes and measuring clinical biomarkers (e.g., Tau). Also provided are kits comprising the peptides or compositions described herein, for use in assays (e.g., sandwich immunoassays).